Evidence map›Paper›PMID 23922698›Full record

ArticlePloS one2013

Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Dionna W Williams, Tina M Calderon, Lillie Lopez, Loreto Carvallo-Torres, Peter J Gaskill, Eliseo A Eugenin, Susan Morgello, Joan W Berman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 1 synthesis or guideline pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Single-cell analysis of CD14Frontiers in immunology · 2025
    Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dionna W WilliamsDepartment of Pathology, the Albert Einstein College of Medicine, Bronx, New York, United States of America.
Tina M Calderon
Lillie Lopez
Loreto Carvallo-Torres
Peter J Gaskill
Eliseo A Eugenin
Susan Morgello
Joan W Berman
Albert Einstein College of Medicine · USIcahn School of Medicine at Mount Sinai · US

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI PORCELLI, STEVEN A · 2003 to 2013
$18.6M
The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
The Manhattan HIV Brain BankU01MH083501 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2008 to 2012
$8.9M
Geographic Medicine and Emerging InfectionsT32AI070117 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WEISS, LOUIS M. · 2008 to 2023
$5.1M
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDSR01MH096625 · NIMH · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI EUGENIN, ELISEO A · 2012 to 2020
$4.5M
Mechanisms of HAD:Role of CCL2 BBB & HIV InfectionR01MH075679 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERMAN, JOAN WEINBERGER · 2006 to 2016
$4.0M
The Mount Sinai Institute for NeuroAIDS DisparitiesR25MH080663 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2007 to 2015
$2.1M
Role of cellular prion protein in the pathogenesis of NeuroAIDSR01MH090958 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERMAN, JOAN WEINBERGER · 2011 to 2015
$1.9M
Dopamine alters CNS migration of uninfected and HIV infected leukocytes to SDF-1R01DA025567 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BERMAN, JOAN WEINBERGER · 2008 to 2012
$1.7M
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic SystemK01DA029476 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GASKILL, PETER JESSE · 2010 to 2014
$728k
NIAID NIH HHS AI-051519NIAID NIH HHS P30 AI051519NIAID NIH HHS T32 AI070117NIDA NIH HHS DA025567NIDA NIH HHS DA029476NIDA NIH HHS K01 DA029476NIDA NIH HHS R01 DA025567NIMH NIH HHS MH075679NIMH NIH HHS MH080663NIMH NIH HHS MH083501NIMH NIH HHS MH090958NIMH NIH HHS MH096625NIMH NIH HHS R01 MH075679NIMH NIH HHS R01 MH090958NIMH NIH HHS R01 MH096625NIMH NIH HHS R25 MH080663NIMH NIH HHS U01 MH083501NIMH NIH HHS U24 MH100931PHS HHS NIAID T32AI070117
6 · The paper itself

Abstract

As HIV infected individuals live longer, the prevalence of HIV associated neurocognitive disorders is increasing, despite successful antiretroviral therapy. CD14(+)CD16(+) monocytes are critical to the neuropathogenesis of HIV as they promote viral seeding of the brain and establish neuroinflammation. The mechanisms by which HIV infected and uninfected monocytes cross the blood brain barrier and enter the central nervous system are not fully understood. We determined that HIV infection of CD14(+)CD16(+) monocytes resulted in their highly increased transmigration across the blood brain barrier in response to CCL2 as compared to uninfected cells, which did not occur in the absence of the chemokine. This exuberant transmigration of HIV infected monocytes was due, at least in part, to increased CCR2 and significantly heightened sensitivity to CCL2. The entry of HIV infected and uninfected CD14(+)CD16(+) monocytes into the brain was facilitated by significantly increased surface JAM-A, ALCAM, CD99, and PECAM-1, as compared to CD14(+) cells that are CD16 negative. Upon HIV infection, there was an additional increase in surface JAM-A and ALCAM on CD14(+)CD16(+) monocytes isolated from some individuals. Antibodies to ALCAM and JAM-A inhibited the transmigration of both HIV infected and uninfected CD14(+)CD16(+) monocytes across the BBB, demonstrating their importance in facilitating monocyte transmigration and entry into the brain parenchyma. Targeting CCR2, JAM-A, and ALCAM present on CD14(+)CD16(+) monocytes that preferentially infiltrate the CNS represents a therapeutic strategy to reduce viral seeding of the brain as well as the ongoing neuroinflammation that occurs during HIV pathogenesis.

Indexed as

Activated-Leukocyte Cell Adhesion MoleculeAntigens, CDBlood-Brain BarrierCell Adhesion MoleculesCell Adhesion Molecules, NeuronalCell MembraneCentral Nervous SystemChemokine CCL2DemographyFetal ProteinsHIV-1HIV InfectionsHumansLipopolysaccharide ReceptorsMiddle AgedMonocytesActivated-Leukocyte Cell Adhesion MoleculeALCAM protein, humanAntigens, CDCCR2 protein, humanCell Adhesion MoleculesCell Adhesion Molecules, NeuronalChemokine CCL2F11R protein, humanFetal ProteinsLipopolysaccharide ReceptorsReceptors, CCR2Receptors, Cell SurfaceReceptors, IgG

Identifiers

PMID23922698
PMCPMC3724935
OpenAlexW2012700090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.